Results 311 to 320 of about 1,519,611 (347)
Some of the next articles are maybe not open access.
American Journal of Cardiovascular Drugs, 2008
*Conivaptan is an arginine vasopressin V1A and V2 receptor antagonist. The intravenous formulation is approved in the US for use in the treatment of euvolemic and hypervolemic hyponatremia. Conivaptan produces a dose-dependent electrolyte-sparing aquaresis (solute-free water excretion), increasing serum sodium levels.
Marit D, Moen, Gillian M, Keating
openaire +2 more sources
*Conivaptan is an arginine vasopressin V1A and V2 receptor antagonist. The intravenous formulation is approved in the US for use in the treatment of euvolemic and hypervolemic hyponatremia. Conivaptan produces a dose-dependent electrolyte-sparing aquaresis (solute-free water excretion), increasing serum sodium levels.
Marit D, Moen, Gillian M, Keating
openaire +2 more sources
New England Journal of Medicine, 1989
To determine the risk of active tuberculosis associated with human immunodeficiency virus (HIV) infection, we prospectively studied 520 intravenous drug users enrolled in a methadone-maintenance program.
P. Selwyn +7 more
semanticscholar +1 more source
To determine the risk of active tuberculosis associated with human immunodeficiency virus (HIV) infection, we prospectively studied 520 intravenous drug users enrolled in a methadone-maintenance program.
P. Selwyn +7 more
semanticscholar +1 more source
Journal of the American Medical Association (JAMA), 2012
CONTEXT Administration of traditional chloride-liberal intravenous fluids may precipitate acute kidney injury (AKI). OBJECTIVE To assess the association of a chloride-restrictive (vs chloride-liberal) intravenous fluid strategy with AKI in critically ...
N. Yunos +5 more
semanticscholar +1 more source
CONTEXT Administration of traditional chloride-liberal intravenous fluids may precipitate acute kidney injury (AKI). OBJECTIVE To assess the association of a chloride-restrictive (vs chloride-liberal) intravenous fluid strategy with AKI in critically ...
N. Yunos +5 more
semanticscholar +1 more source
The Future of Intravenous Therapy
AJN, American Journal of Nursing, 1971Techniques for the initial insertion of the infusion, the care of the infusion site, and the handling of the infusion solution have reduced some of the hazards of I.V. therapy. Now, new designs in infusion equipment may help to further reduce these risks.
openaire +4 more sources
Intravenous cannulation, intravenous infusion and prescription of intravenous fluids
The Foundation Years, 2009Peter Winstanley +2 more
openaire +2 more sources
Best Practice & Research Clinical Anaesthesiology, 2017
Lidocaine has analgesic effect and antihyperalgesic and anti-inflammatory properties, which enable its use as a general anesthetic adjuvant. Lidocaine can reduce nociception and/or cardiovascular responses to surgical stress, postoperative pain, and/or analgesic requirements. However, its mechanisms of action remain unclear, despite its different known
openaire +2 more sources
Lidocaine has analgesic effect and antihyperalgesic and anti-inflammatory properties, which enable its use as a general anesthetic adjuvant. Lidocaine can reduce nociception and/or cardiovascular responses to surgical stress, postoperative pain, and/or analgesic requirements. However, its mechanisms of action remain unclear, despite its different known
openaire +2 more sources